Evidence map›Paper›PMID 31582797›Full record

ArticleScientific reports2019

HERC2 regulates RPA2 by mediating ATR-induced Ser33 phosphorylation and ubiquitin-dependent degradation.

Yongqiang Lai, Mingzhang Zhu, Wenwen Wu, Nana Rokutanda, Yukiko Togashi, Weixin Liang, Tomohiko Ohta

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Loss of MNX1 Sensitizes Tumors to Cytotoxic T Cells by Degradation of PD-L1 mRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yongqiang LaiDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Mingzhang ZhuDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Wenwen WuDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Nana RokutandaDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Yukiko TogashiDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan.
Weixin LiangDepartment of General Surgery, The People's Hospital of Gaoming District of Foshan City, Foshan city, Guangdong province, China.
Tomohiko OhtaDepartment of Translational Oncology, St. Marianna University Graduate School of Medicine, Kawasaki, Japan. to@marianna-u.ac.jp.
St. Marianna University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Replication protein A (RPA) binds to and stabilizes single-stranded DNA and is essential for the genome stability. We reported that an E3 ubiquitin ligase, HERC2, suppresses G-quadruplex (G4) DNA by regulating RPA-helicase complexes. However, the precise mechanism of HERC2 on RPA is as yet largely unknown. Here, we show essential roles for HERC2 on RPA2 status: induction of phosphorylation and degradation of the modified form. HERC2 interacted with RPA through the C-terminal HECT domain. Ubiquitination of RPA2 was inhibited by HERC2 depletion and rescued by reintroduction of the C-terminal fragment of HERC2. ATR-mediated phosphorylation of RPA2 at Ser33 induced by low-level replication stress was inhibited by depletion of HERC2. Contrary, cells lacking HERC2 catalytic residues constitutively expressed an increased level of Ser33-phosphorylated RPA2. HERC2-mediated ubiquitination of RPA2 was abolished by an ATR inhibitor, supporting a hypothesis that the ubiquitinated RPA2 is a phosphorylated subset. Functionally, HERC2 E3 activity has an epistatic relationship with RPA in the suppression of G4 when judged with siRNA knockdown experiments. Together, these results suggest that HERC2 fine-tunes ATR-phosphorylated RPA2 levels through induction and degradation, a mechanism that could be critical for the suppression of secondary DNA structures during cell proliferation.

Indexed as

Guanine Nucleotide Exchange FactorsHCT116 CellsHEK293 CellsHeLa CellsHumansPhosphorylationProtein Interaction MapsProtein SubunitsProteolysisReplication Protein AUbiquitinUbiquitinationUbiquitin-Protein LigasesGuanine Nucleotide Exchange FactorsHERC2 protein, humanProtein SubunitsReplication Protein ARPA2 protein, humanUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID31582797
PMCPMC6776656
OpenAlexW2977582344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.